切換帳號

  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 登入

全站搜尋

台灣泌尿科醫學會E-School
  • 登入
  • FAQ
    • 新手指南
    • FAQ常見問題
  • 學術會議
  • 影音網
  • 到官網
  • Home
  • 到官網
  • Home
知識庫
  • 目錄總覽
  • 文件總覽
  • 最新討論
目錄 / 資料夾
  • 學術活動與演講
    • 年會
      • 2026年會
        • 摘要
      • 2026半年會
        • 摘要
      • 2025年會 (UAA)
        • 摘要
      • 2025半年會
        • 摘要
      • 2024年會
        • 摘要
      • 2024半年會
        • 摘要
      • 2023年會
        • 摘要
      • 2023半年會
        • 摘要
      • 2022年會
        • 摘要
      • 2021年會
        • 摘要
      • 2021半年會
        • 摘要
      • 2020年會
        • 摘要
      • 2020半年會
        • 摘要
      • 2019年會
        • 摘要
      • 2019半年會
        • 摘要
      • 2018年會
        • 摘要
      • 2018半年會
        • 摘要
      • 2017年會
        • 摘要
      • 2017半年會
        • 摘要
      • 2016年會
        • 摘要
      • 2016半年會
        • 摘要
      • 2015年會
        • 摘要
  • 新手指南與FAQ
  1. 知識庫
  2. 熱門媒體

熱門媒體
(
  • 最新
)

熱門媒體

(
  • 最新
)
NDP11: Rare differential diagnosis of hematuria: A case report and review of diffuse large B-cell lymphoma
1506 觀看
NDP012: What PET/CT acquired interval after 18F-PSMA-1007 injection among patients with suspected prostate cancer is better- a report of case series?
1506 觀看
PD03-4: Risk factors and management of fournier's gangrene: An 18-year retrospective study
1505 觀看
MP03-08: Suppression of bone metastatic castration-resistant prostate cancer cell growth by a suicide gene delivered by JC polyomavirus-like particles
1503 觀看
MP05-09: Suppression of tumor characteristics of urothelial carcinoma cells by berberrubine and resveratrol by GSTM2 induction
1502 觀看
(MP3-10) Postoperatively increased splenic volume correlates with an unfavorable prognosis in patients after radical nephroureterectomy to treat upper tract urothelial carcinoma
1502 觀看
NPD53: Diagnosis of Renal Arteriovenous Malformation by Flexible Ureterorenoscopy: A Case Report
1502 觀看
MP04-07: Obesity-related indices and its association with kidney stone
1501 觀看
PD05-02: Prognostic factors of disease progression in patients with locally advanced renal cell carcinoma
1501 觀看
NDP097: A case of adrenal pheochromocytoma presenting as hyperaldosteronism and secondary hypertension: Case report and literature review
1501 觀看
MP08-02: External validation of pre-operative nomogram for prediction of non-organ confined upper urinary tract urothelial carcinoma in central Taiwan population
1499 觀看
MP01-07: Therapeutic outcome of active management in male patients with detrusor underactivity based on clinical diagnosis and videourodynamic classification
1497 觀看
MP05-03: Influence of novel inflammatory biomarkers on prediction for patients with upper tract urothelial carcinoma
1496 觀看
MP05-08: Efficiency and prognosis of enucleation turbt versus traditional turbt– VGHTC experience
1495 觀看
MP08-03: The characteristics of end stage renal disease patients with upper urinary tract urothelial cancer treated with radical nephroureterectomy: A single center experience
1495 觀看
NDP054: The clinical presentation and treatment outcome of Mtor inhibitor in epithelioid angiomyolipoma : A case report and literature review
1495 觀看
NDP086: Pulmonary embolism after moderna vaccination in kidney transplant: two-case reports and literature review
1495 觀看
MP03-03: New treatment strategies for overcoming the chemoresistance of urothelial carcinoma
1494 觀看
NPD03: Zinner syndrome complicated with primary adenocarcinoma of seminal vesicle: A case report and literature review
1494 觀看
PD05-03: Early postoperative outcomes of retroperitoneal partial nephrectomy of anterior and posterior renal tumors: A five-year experience in a single center
1493 觀看
NDP005: Sporadic extraneural hemangioblastoma associated with polycythemia
1492 觀看
NDP068: Bladder stone forming on migrated surgical clip ten years after robotic-assisted radical prostatectomy: A case report and literature review
1491 觀看
(MP3-07) Comparison of Standard Transurethral Resection of Bladder Tumor and Laser En-bloc Resection of Bladder Tumor: A Single-centered Experience from Taipei Municipal Wanfang Hospital
1489 觀看
MP03-03: Real world experience of metastatic urothelial carcinoma treated with immune check point inhibitors
1486 觀看
  • <
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • >
/ 163
地址:台北市 11051 信義區基隆路一段432號6樓之1, 電話:02-2729-0819, 傳真:02-2729-0864
網址: http://eschool.tua.org.tw,  EMail: eschool@tua.org.tw